FINANCIAL STATEMENTS AND OTHER INFORMATION 146 NOTES TO THE SUMMARY COMBINED FINANCIAL INFORMATION IN EUROS Notes to the summary combined financial information in euros 1 Segment analysis ANALYSIS BY BUSINESS SEGMENT Revenue Operating profit Adjusted operating profit Restated Restated 2013 2012 2013 2012 2013 2012 m m m m m m Scientific, Technical & Medical 2,509 2,538 876 868 975 960 Risk Solutions 1,101 1,139 368 346 489 482 Business Information 645 815 84 93 126 146 Legal 1,849 1,980 164 180 281 288 Exhibitions 1,017 1,051 190 210 251 258 Sub-total 7,121 7,523 1,682 1,697 2,122 2,134 Corporate costs 58 58 58 58 Total 7,121 7,523 1,624 1,639 2,064 2,076 Share of post-tax results of joint ventures of 35m 2012: 29m included in operating profit comprises 7m 2012: 2m relating to Legal and 28m 2012: 27m relating to Exhibitions.
ANALYSIS OF REVENUE BY GEOGRAPHICAL ORIGIN 2013 2012 m m North America 3,661 3,840 United Kingdom 1,162 1,188 The Netherlands 774 752 Rest of Europe 824 969 Rest of world 700 774 Total 7,121 7,523 ANALYSIS OF REVENUE BY GEOGRAPHICAL MARKET 2013 2012 m m North America 3,637 3,879 United Kingdom 523 544 The Netherlands 196 203 Rest of Europe 1,267 1,447 Rest of world 1,498 1,450 Total 7,121 7,523 ANALYSIS OF REVENUE BY FORMAT 2013 2012 m m Electronic 4,686 4,792 Print 1,378 1,605 Face to face 1,057 1,126 Total 7,121 7,523 29275 SAS p140-154 SUMCOMB FININFO EUROS.
indd 146 07 03 2014 11:31 Overview Business review Financial review Governance Financial statements and other information Reed Elsevier Annual Reports and Financial Statements 2013 147 1 Segment analysis continued ANALYSIS OF REVENUE BY TYPE 2013 2012 m m Subscriptions 3,672 3,663 Transactional 3,166 3,429 Advertising 283 431 Total 7,121 7,523 ANALYSIS BY BUSINESS SEGMENT Expenditure on Capital Amortisation acquired goodwill and expenditure of acquired Depreciation and intangible assets additions intangible assets other amortisation 2013 2012 2013 2012 2013 2012 2013 2012 m m m m m m m m Scientific, Technical & Medical 59 148 110 130 90 84 112 101 Risk Solutions 193 18 30 26 114 134 26 28 Business Information 6 21 21 37 46 12 17 Legal 18 98 200 213 87 102 127 113 Exhibitions 66 219 18 31 47 39 17 20 Total 342 483 379 421 375 405 294 279 Capital expenditure comprises additions to property, plant and equipment and internally developed intangible assets.
Amortisation of acquired intangible assets includes amounts in respect of joint ventures of 1m 2012: 1m in Exhibitions.
Other than the depreciation and amortisation above, non cash items include 37m 2012: 38m relating to the recognition of share based remuneration and comprise 7m 2012: 6m in Scientific, Technical & Medical, 4m 2012: nil in Risk Solutions, 2m 2012: 4m in Business Information, 7m 2012: 8m in Legal, 5m 2012: 5m in Exhibitions and 12m 2012: 15m in Corporate.
ANALYSIS OF NON-CURRENT ASSETS BY GEOGRAPHICAL LOCATION 2013 2012 m m North America 7,549 8,012 United Kingdom 701 645 The Netherlands 150 148 Rest of Europe 904 897 Rest of world 481 462 Total 9,785 10,164 Non-current assets by geographical location exclude amounts relating to deferred tax assets and derivative financial instruments.
